Schedule of Items Measured at Fair Value on Nonrecurring Basis |
During 2020 and 2021, the Company was impacted by the COVID-19 Pandemic (Note 11), which caused the Company to reduce its holding periods and forecasted operating income at certain properties. As a result, several impairments were recorded. Impairment charges for the periods presented are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment Charge |
|
Property and Location |
|
Owner |
|
Triggering Event |
|
Level 3 Inputs |
|
Effective Date |
|
Total |
|
|
Acadia's Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 Impairment Charges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210 Bowery, Manhattan, NY |
|
Fund IV |
|
Reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Sept 30, 2021 |
|
$ |
3,016 |
|
|
$ |
697 |
|
27 E. 61st Street Manhattan, NY |
|
Fund IV |
|
Reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Sept 30, 2021 |
|
|
6,909 |
|
|
|
1,597 |
|
Total 2021 Impairment Charges |
|
|
|
|
|
|
|
|
|
$ |
9,925 |
|
|
$ |
2,294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 Impairment Charges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cortlandt Crossing, Mohegan Lake, NY |
|
Fund III |
|
Reduced holding period, reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Mar 31, 2020 |
|
$ |
27,402 |
|
|
$ |
6,726 |
|
654 Broadway, New York, NY |
|
Fund III |
|
Reduced holding period |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Mar 31, 2020 |
|
|
6,398 |
|
|
|
1,570 |
|
146 Geary Street, San Francisco, CA |
|
Fund IV |
|
Reduced holding period, reduced projected operating income |
|
Projections of: holding period, net operating |
|
Mar 31, 2020 |
|
|
6,718 |
|
|
|
1,553 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
income, cap rate, incremental costs |
|
|
|
|
|
|
|
|
|
|
801 Madison Avenue, New York, NY |
|
Fund IV |
|
Reduced holding period, reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Mar 31, 2020 |
|
|
11,031 |
|
|
|
2,551 |
|
717 N. Michigan Avenue, Chicago, IL |
|
Fund IV |
|
Reduced holding period, reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Dec 31, 2020 |
|
|
17,392 |
|
|
|
4,021 |
|
110 University, New York, NY |
|
Fund IV |
|
Reduced holding period, reduced projected operating income |
|
Projections of: holding period, net operating income, cap rate, incremental costs |
|
Dec 31, 2020 |
|
|
16,238 |
|
|
|
3,754 |
|
Fifth Wall Investment |
|
Core |
|
Decline in fair value |
|
Projections of: reported fair value of net assets |
|
Dec 31, 2020 |
|
|
419 |
|
|
|
419 |
|
Total 2020 Impairment Charges |
|
|
|
|
|
|
|
|
|
$ |
85,598 |
|
|
$ |
20,594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Derivative Financial Instruments |
The Company had the following interest rate swaps and caps for the periods presented (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Strike Rate |
|
|
|
|
Fair Value |
|
Derivative Instrument |
|
Aggregate Notional Amount |
|
|
Effective Date |
|
Maturity Date |
|
Low |
|
|
|
High |
|
|
Balance Sheet Location |
|
September 30, 2021 |
|
|
December 31, 2020 |
|
Core |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swaps |
|
$ |
539,636 |
|
|
Dec 2012-Jul 2020 |
|
Mar 2022-Jul 2030 |
|
|
1.71 |
% |
|
— |
|
|
3.77 |
% |
|
Other Liabilities |
|
$ |
(46,731 |
) |
|
$ |
(74,990 |
) |
|
|
$ |
539,636 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(46,731 |
) |
|
$ |
(74,990 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund II |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swap |
|
$ |
18,588 |
|
|
Oct 2014 |
|
Nov 2021 |
|
|
1.49 |
% |
|
— |
|
|
1.49 |
% |
|
Other Liabilities |
|
$ |
(23 |
) |
|
$ |
(219 |
) |
Interest Rate Cap |
|
|
45,000 |
|
|
Mar 2019 |
|
Mar 2022 |
|
|
3.50 |
% |
|
— |
|
|
3.50 |
% |
|
Other Assets |
|
|
— |
|
|
|
— |
|
|
|
$ |
63,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(23 |
) |
|
$ |
(219 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund III |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Caps |
|
$ |
35,970 |
|
|
Jan 2021 |
|
Jul 2022 |
|
|
3.00 |
% |
|
— |
|
|
3.00 |
% |
|
Other Assets |
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund IV |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swaps |
|
$ |
42,385 |
|
|
Mar 2017-Dec 2019 |
|
Apr 2022-Dec 2022 |
|
|
1.48 |
% |
|
— |
|
|
2.61 |
% |
|
Other Liabilities |
|
$ |
(528 |
) |
|
$ |
(1,713 |
) |
Interest Rate Caps |
|
|
71,338 |
|
|
Dec 2020 - Jul 2021 |
|
Dec 2022-Jul 2023 |
|
|
3.00 |
% |
|
— |
|
|
3.50 |
% |
|
Other Assets |
|
|
2 |
|
|
|
1 |
|
|
|
$ |
113,723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(526 |
) |
|
$ |
(1,712 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund V |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swaps |
|
$ |
298,014 |
|
|
Jun 2018-Feb 2021 |
|
Feb 2022-Oct 2024 |
|
|
0.23 |
% |
|
— |
|
|
2.88 |
% |
|
Other Liabilities |
|
$ |
(7,545 |
) |
|
$ |
(13,217 |
) |
|
|
$ |
298,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(7,545 |
) |
|
$ |
(13,217 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total asset derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2 |
|
|
$ |
1 |
|
Total liability derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(54,827 |
) |
|
$ |
(90,139 |
) |
|
Schedule of Other Financial Instruments Carrying Values and Fair values |
The Company’s other financial instruments had the following carrying values and fair values as of the dates shown (dollars in thousands, inclusive of amounts attributable to noncontrolling interests where applicable):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
|
|
December 31, 2020 |
|
|
|
Level |
|
|
Carrying Amount |
|
|
Estimated Fair Value |
|
|
Carrying Amount |
|
|
Estimated Fair Value |
|
Notes Receivable (a) |
|
|
3 |
|
|
$ |
158,468 |
|
|
$ |
159,476 |
|
|
$ |
101,450 |
|
|
$ |
102,135 |
|
Mortgage and Other Notes Payable (a) |
|
|
3 |
|
|
|
1,185,228 |
|
|
|
1,165,716 |
|
|
|
1,210,540 |
|
|
|
1,190,214 |
|
Investment in non-traded equity securities (b) |
|
|
3 |
|
|
|
3,021 |
|
|
|
3,772 |
|
|
|
1,726 |
|
|
|
1,456 |
|
Unsecured notes payable and Unsecured line of credit (c) |
|
|
2 |
|
|
|
610,981 |
|
|
|
616,056 |
|
|
|
559,514 |
|
|
|
544,532 |
|
(a)The Company determined the estimated fair value of these financial instruments using a discounted cash flow model with rates that take into account the credit of the borrower or tenant, where applicable, and interest rate risk. The Company also considered the value of the underlying collateral, taking into account the quality of the collateral, the credit quality of the borrower, the time until maturity and the current market interest rate environment. (b)Represents the Operating Partnership’s cost-method investment in Fifth Wall (Note 4). (c)The Company determined the estimated fair value of the unsecured notes payable and unsecured line of credit using quoted market prices in an open market with limited trading volume where available. In cases where there was no trading volume, the Company determined the estimated fair value using a discounted cash flow model using a rate that reflects the average yield of similar market participants.
|